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We have raised antibodies against a synthetic dodecapeptide corresponding to the carboxyl terminus of the 
predicted met gene product. Phosphorylation of 60 kDa and 65 kDa proteins on tyrosine residues was ob- 
served when immunoprecipitates of cells containing the activated human met gene were incubated with 
[Y-~~P]ATP. hosphoproteins with the same molecular masses could be immunoprecipitated from cells meta- 
bolically labelled with [32P]orthophosphate. When considered together, these observations indicate that the 
activated human met gene encodes 60 kDa and 65 kDa proteins that can catalyse autophosphorylation on 
tyrosine residues. 
Antipeptide antibody met oncogene Tyrosine kinase 
1. INTRODUCTION 
The activated met gene present in the MNNG- 
HOS chemically transformed human cell line was 
originally identified by its ability to transform 
NIH3T3 mouse fibroblasts in DNA transfection 
experiments [1,2]. Activation of met involves a 
chromosomal rearrangement that generates a 
chimeric gene containing 5 ’ -sequences (designated 
tpr) derived from chromosome 1, and 3 ‘-se- 
quences (designated met) derived from 
chromosome 7 [3,4]. DNA sequence analysis has 
demonstrated that the 3 ’ -region of activated met is 
related to the tyrosine kinase domains of the 
human insulin and epidermal growth factor (EGF) 
receptors, indicating that in common with these 
two receptors activated met may also encode a pro- 
tein tyrosine kinase [5]. To directly examine 
whether met encodes a protein tyrosine kinase we 
have raised antibodies against a synthetic peptide 
corresponding to the 12 amino acids at the 
* To whom correspondence should be addressed 
carboxyl-terminus of the predicted met gene prod- 
uct and used these antibodies to precipitate met 
related products from cells containing the ac- 
tivated human met gene. 
2. MATERIALS AND METHODS 
2.1. Cell lines 
All cell lines including human HOS and MNNG- 
HOS [6] and untransformed and transformed 
NIH3T3 mouse fibroblasts were grown in Dulbec- 
co’s modified Eagle’s medium (DMEM) contain- 
ing 10% foetal calf serum. 
2.2. Antipeptide antibodies 
A peptide of sequence VDTRPASFWETS was 
synthesized by Cambridge Research Biochemicals, 
Cambridge, England. The peptide was coupled to 
Keyhole limpet haemocyanin and the conjugate 
used to immunize New Zealand White rabbits as 
described [7]. Rabbit serum was examined for its 
ability to bind the peptide, which was immobilized 
in microtitre dishes, by an enzyme-linked im- 
munosorbent assay (ELISA) that utilized 
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horseradish peroxidase [8]. Peroxidase activity, 
which is proportional to the amount of binding of 
antibody to peptide, was assayed with o- 
phenylenediamine after which the absorbance at 
492 nm was measured [8]. Antipeptide antibodies 
used in some experiments were purified by 
chromatography on affinity columns of im- 
mobilized synthetic peptide [7]. 
2.3. Immunoprecipitations and kinase assays 
Lysates of unlabelled cells and of cells that were 
incubated for 5-6 h in phosphate-free DMEM 
(without added foetal calf serum), containing 
0.35-0.7 mCi . ml-’ carrier-free [32P]orthophos- 
phate (Amersham International), were prepared as 
described [7]. Antibody-protein A-Sepharose com- 
plexes for immunoprecipitations were prepared by 
incubating 20~1 of protein A-Sepharose [50% 
(v/v) in phosphate-buffered saline] with an equal 
volume of either phosphate-buffered saline con- 
taining 1 pg of affinity-purified antibody or un- 
purified serum for 20 min at 22°C. The washed 
antibody-protein A-Sepharose complexes were 
then incubated with cell lysates either in the 
absence or presence of immunizing peptide at 
1 mM for 3-16 h at 4°C. To assay for kinase ac- 
tivity, immunoprecipitates from unlabelled cells 
were washed 5 times with HNTG [20 mM Hepes, 
pH 7.5, 150 mM NaCl, 0.1% (v/v) Triton X-100, 
10% (v/v) glycerol] and were resuspended in 40 ~1 
of HNTG containing 5 mM MnClz and 3 ,&i 
[T-~~P]ATP (5000 Ci - mmoll’; Amersham Inter- 
national). After incubation at 22°C for 15 min, 
sample buffer containing 2-mercaptoethanol was 
added, and precipitated proteins were solubilized 
by boiling for 3 min before being subjected to elec- 
trophoresis through a 7.5% polyacrylamide gel 
containing SDS [9]. Immunoprecipitates from 
[32P]orthophosphate-labelled cells were washed as 
described [7] and proteins subjected to SDS- 
PAGE. To detect phosphorylated proteins, the 
gels were fixed, dried and subjected to 
autoradiography at -70°C for 1-16 h using Fuji 
RX film. 
2.4. Phosphoamino acid analysis 
Phosphorylated proteins were located in 
polyacrylamide gels by autoradiography, eluted 
from the gels after trypsin digestion [7] and 
hydrolysed with constant-boiling HCl at 110°C for 
358 
75 min. The lyophilized hydrolysate was dissolved 
in a solution containing phosphoserine, phospho- 
threonine and phosphotyrosine and subjected to 
anion-exchange high-performance liquid chroma- 
tography (HPLC) [lo]. The positions of elution of 
authentic phosphoamino acids were determined by 
fluorescence spectroscopy after post-column 
derivatization with o-phthalaldehyde [ 111. 
Radioactivity in the eluent fractions (0.75 ml) was 
detected by Cerenkov counting. 
3. RESULTS AND DISCUSSION 
The amino acid sequence of portions of the pro- 
tein encoded by the met gene may be deduced from 
partial DNA sequence analysis [5]. To facilitate the 
analysis of proteins encoded by met we have raised 
antibodies to a synthetic peptide that corresponds 
to the carboxyl-terminus of the predicted amino 
acid sequence. Sera from rabbits immunized with 
peptide conjugated to Keyhole limpet haemo- 
cyanin were analysed for their abilities to bind the 
synthetic peptide using an ELISA. The results ob- 
tained using immune serum from one rabbit are 
shown in fig.1. Binding of the antiserum to the 
synthetic peptide was detected at dilution of the 
serum up to 1 in 40960 indicating that high titres 
of the antipeptide antibody had been obtained. 
The specificity of the antiserum was confirmed in 
control experiments where we failed to detect 
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Fig.1. Titres of antipeptide antibodies present in 
preimmune serum (0) and in immune serum (0) from 
the same rabbit determined by ELISA. The absorbance 
at 492 nm is proportional to the amount of antibody 
bound to peptide. 
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binding of the preimmune serum to peptide {fig. 1). 
Evidence that the met gene encodes a protein 
kinase was obtained in experiments in which pro- 
teins immunoprecipitated with antipeptide an- 
tiserum were incubated in the presence of 
[Y-~~P)ATP. Immunoprecipitated proteins were 
analysed by SDS-polyacrylamide gel elec- 
trophoresis and in vitro phosphorylation of pro- 
teins was detected by autoradiography. The results 
of these analyses are shown in fig.2. Phosphoryla- 
tion of a 60 kDa protein and less extensive 
phosphorylation of a 65 kDa protein were ob- 
served in immunoprecipitates of MNNG-HOS cells 
and of a line of NIH3T3 mouse fibroblasts (22-la) 
transformed by the activated human met gene. 
Precipitation of the cellular component responsi- 
ble for this phospho~lation was blocked when im- 
munoprecipitations were carried out either in the 
presence of an excess of immunizing peptide or us- 
ing preimmune, instead of immune serum. No 
phosphorylation of the 60 and 65 kDa proteins 
was observed in experiments with cells that do not 
express the activated met gene. The cell lines ex- 
amined included untransformed NIH3T3 cells, a 
line of spontaneously transformed NIH3T3 cells 
HUS 
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designated ST10 [ 121 and HOS cells, the parent cell 
line from which the MNNG-HOS cells were 
originally derived by treatment with N-methyl- 
iV’-nitro-N-nitrosoguanidine [6]. 
Evidence that the major site of protein 
phosphorylation is on tyrosine was obtained by 
subjecting an acid hydrolysate of the 32P-labelled 
60 kDa phosphoprotein, which had been extracted 
from a polyacrylamide gel, to HPLC on an anion- 
exchange column in admixture with unlabelled 
phosphoserine, phosphothreonine and phospho- 
tyrosine. The results in fig.3 show that a single 
major peak of radioactive material coeluted with 
phosphotyrosine. Little or no radioactive material 
eluted at positions corresponding to phosphoserine 
and phosphothreonine. Parallel experiments with 
acid hydrolysates of the 32P-labelled 65 kDa 
phosphoprotein demonstrated that the major site 
of phosphorylation of this protein also occurred 
on tyrosine residues (not shown). 
Many protein tyrosine kinases, including the 
EGF and insulin receptors, can catalyse their own 
phosphorylation [13,14], and by analogy it seemed 
probable that phosphorylation of the 60 and 
65 kDa proteins may result from autophosphory- 
224r 
P t I* 
Fig.2. Autoradiograph of immunoprecipitated proteins that had been incubated in vitro with [T-~‘P]ATP and analysed 
by SDS-PAGE. Immunoprecipitations were carried out with preimmune serum (P) and with immune serum either in 
the absence (I -) or presence (I +) of immunizing peptide. Molecular mass standards are indicated in kDa. 
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P-Tyr Fig.3. Anion-exchange HPLC of an acid hydrolysate of 
1 
the 60 kDa protein that was radiolabelled when an 
immunoprecipitate from 22-la cells was incubated with 
[T-~~P]ATP. The elution positions of the unlabelled 
400 - phosphoamino acid markers, indicated by arrows, were 
3 determined by fluorescence spectroscopy. 
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gene. To obtain evidence that the activated met 
-: c gene encodes these 60 and 65 kDa proteins, anti- 
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ucts of the met gene from cells that had been 
z t metabolically labelled with [32P]orthophosphate. 
loo- Affinity purified antipeptide antibodies were used 
for these studies because non-specific precipitation 
of phosphoproteins was observed in preliminary 
experiments using unpurified antiserum. As ex- 
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petted, 60 and 65 kDa phosphoproteins were 
precipitated from MNNG-HOS and from 22-la 
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cells (fig.4). These phosphoproteins were not 
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Fig.4. Autoradiograph of proteins immunoprecipitated from cells incubated with [32P]orthophosphate and analysed by 
SDS-PAGE. Immunoprecipitations were carried out with affinity-purified antipeptide antibodies either in the absence 
(- ) or presence (+ ) of immunizing peptide. Molecular mass standards are indicated in kDa. 
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detected when immunoprecipitations were carried 
out in the presence of an excess of immunizing 
peptide and were not detected in experiments with 
untransformed NIH3T3 cells, with spontaneously 
transformed NIH3T3 cells (STlO) or with the 
parent HOS cell line. When considered together, 
the data presented here provide evidence that the 
activated human met gene encodes 60 and 65 kDa 
proteins that can catalyse autophosphorylation on 
tyrosine. The relationship between these two pro- 
teins is not clear however. It is conceivable that the 
60 kDa protein could be formed from the 65 kDa 
protein by degradation during cell lysis. Alter- 
natively, one of these two proteins might be de- 
rived from the other by post-translational 
modification. 
Although the proteins encoded by the unrear- 
ranged met gene have been studied less extensively, 
phospho~lation of a 140 kDa and a 165 kDa pro- 
tein was detected when immunoprecipitates of 
HOS cells and MNNG-HOS cells, which both con- 
tain transcripts from the unrearranged met gene 
131, were incubated with fy-32P]ATP (fig.2). 
Phosphorylation of these 140 and 165 kDa pro- 
teins was not observed with immunoprecipitates 
from cells, including K562 and HL60, that do not 
contain detectable levels of met transcripts [3] (not 
shown). Precipitation of the cellular component 
responsible for this phosphorylation was blocked 
when immunoprecipitations were carried out in the 
presence of an excess of immunizing peptide 
(fig.2). These results indicate that the normal met 
gene also encodes a protein tyrosine kinase and it 
is likely that 32P-labelling of the 140 and 165 kDa 
proteins results from autophosphorylation of the 
products encoded by the normal met gene. Our 
failure to detect these 140 and 165 kDa 
phosphoproteins in cells labelled with [32P]or- 
thophosphate may reflect the low level of 
phosphorylation of these proteins under the condi- 
tions that we have used for metabolic labelling. 
Further experiments will be necessary to firmly 
establish the identity of the proteins encoded by 
the normal met gene and to determine the relation- 
ship between the 60 and 65 kDa proteins encoded 
by the activated met gene. 
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